# Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia

> **NCT04466007** · PHASE2 · COMPLETED · sponsor: **Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz** · enrollment: 90 (actual)

## Conditions studied

- Limb Ischemia
- Diabetic Foot

## Interventions

- **DRUG:** High dose allogeneic mesenchymal stromal cells
- **DRUG:** Low dose allogeneic mesenchymal stromal cells
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04466007
- **Lead sponsor:** Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-11
- **Primary completion:** 2024-05-27
- **Final completion:** 2024-12-05
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-04-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04466007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04466007, "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04466007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*